BioAro has partnered with GeneOnline to enhance genetic testing and data analysis across the Asia-Pacific region. The other terms of the partnership were undisclosed.
The collaboration aims to standardize and speed up genetic testing processes, allowing patients to receive more accurate and rapid results. By employing BioAro's PanOmiQ technology for real-time genomics solutions and GeneOnline's market access and strategic connections within Asia, the partnership expects to introduce innovative technologies in genetic testing and drive market growth.
Analyst QuickTake: The PanOmicQ platform was launched globally in May 2024 , during the Precision Medicine Expo at the Dubai World Trade Center. With capabilities such as microbial community analysis (metagenomics), pharmacogenomics, and multi-omics analysis, it is designed to identify biomarkers affected by lifestyle, medications, and environment, aiding personalized interventions for complex disorders.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.